Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease

Vaccine

Volumn 29, Issue 9, 2011, Pages 1830-1835

  Alonso Padilla, Julio ^a   de Oya, Nereida Jiménez ^a   Blázquez, Ana Belén ^a   Escribano Romero, Estela ^a   Escribano, José M ^a   Saiz, Juan Carlos ^a  

^a INIA   (Spain)

Author keywords

Insect biofactories; Passive immune transfer; Vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; RECOMBINANT WEST NILE VIRUS ENVELOPE PROTEIN E; UNCLASSIFIED DRUG; VIRUS RNA; WEST NILE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTHROPOD LARVA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; IMMUNOGENICITY; LACTATION; MOUSE; NONHUMAN; PLACENTAL TRANSFER; PRIORITY JOURNAL; PROGENY; PROTEIN DOMAIN; PROTEIN PURIFICATION; VIRUS INFECTIVITY; VIRUS STRAIN; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

EID: 79952700813     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.081     Document Type: Article

References (44)

1. Smithburn KC, Hughes TP, Burke AW, Paul JH. Aneurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940;20:471-92.
2. Blitvich BJ. Transmission dynamics and changing epidemiology of West Nile virus. Anim Health Res Rev 2008;9(1):71-86.
3. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999;286(5448):2333-7.
4. Anderson JF, Andreadis TG, Vossbrinck CR, Tirrell S, Wakem EM, French RA. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science 1999;286(5448):2331-3.
5. Shrestha B, Gottlieb D, Diamond MS. Infection and injury of neurons by West Nile encephalitis virus. J Virol 2003;77(24):13203-13.
6. Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005;11(8):1174-9.
7. Dauphin G, Zientara S. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine 2007;25(30):5563-76.
8. Brinton MA. The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol 2002;56:371-402.
9. Mukhopadhyay S, Kim BS, Chipman PR, Rossmann MG, Kuhn RJ. Structure of West Nile virus. Science 2003;302(5643):248.
10. Mehlhop E, Diamond MS. The molecular basis of antibody protection against West Nile virus. Curr Top Microbiol Immunol 2008;317:125-53.
11. Tardei G, Ruta S, Chitu V, Rossi C, Tsai TF, Cernescu C. Evaluation of immunoglobulin M(IgM) and IgGenzyme immunoassaysinserologic diagnosis of West Nile Virus infection. J Clin Microbiol 2000;38(6):2232-9.
12. Córdoba L, Escribano-Romero E, Garmendia A, Saiz JC. Pregnancy increases the risk of mortality in West Nile virus-infected mice. J Gen Virol 2007;88(2):476-80.
13. Jiménez de Oya N, Galindo I, Escribano-Romero E, Blázquez AB, Alonso-Padilla J, Halaihel N, et al. Expression and immunoreactivities of hepatitis E virus geno-type3 open reading frame-2 (ORF-2) recombinant proteins expressedin insect cells. Food Environ Virol 2009;1(1):77-84.
14. Alonso-Padilla J, Jiménez de Oya N, Blázquez AB, Loza-Rubio E, Escribano JM, Saiz JC, et al. Evaluation of an enzyme-linked immunosorbent assay for detection of West Nile virus infection based on a recombinant envelope protein produced in Trichoplusia ni larvae. J Virol Methods 2010;166(1-2):37-41.
15. Medin JA, Hunt L, Gathy K, Evans RK, Coleman MS. Efficient, low-cost protein factories: expression of human adenosine deaminase in baculovirus-infected insect larvae. Proc Natl Acad Sci USA 1990;87(7):2760-4.
16. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005;23(5):567-75.
17. Liu Y, DeCarolis N, Beck N. Protein production with recombinant baculoviruses in lepidopteran larvae. Methods Mol Biol 2007;388:267-80.
18. Jiménez de Oya N, Galindo I, Gironés O, Duizer E, Escribano JM, Saiz JC. Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae. J Clin Microbiol 2009;47(10):3276-82.
19. Pérez-Filgueira DM, González-Camacho F, Gallardo C, Resino-Talaván P, Blanco E, Gómez-Casado E, et al. Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae. J Clin Microbiol 2006;44(9):3114-21.
20. Despres P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J Infect Dis 2005;191(2):207-14.
21. Beaty BJ, Calisher CH, Shope RE. Diagnostic procedures for viral, rickettsial, and chamydial infections. In: Schmidt NJ, Emmons RW, editors. Arbo viruses. 6th ed. Washington, DC: American Public Health Association; 1989. p. 795-855.
22. Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, Savage HM, et al. Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 2000;38(11):4066-71.
23. Blázquez A, Saiz JC. West Nile virus transmission routes in the murine model: intrauterine, by breastfeeding and after cannibal ingestion. Virus Res 2010;151(2):240-3.
24. Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, etal. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 2005;11(5):522-30.
25. Zohrabian A, Hayes EB, Petersen LR. Cost-effectiveness of West Nile virus vaccination. Emerg Infect Dis 2006;12(3):375-80.
26. Diamond MS. Virus and host determinants of West Nile virus pathogenesis. PLoS Pathog 2009;5(6):e1000452.
27. Seligman SJ, Gould E. Live flavivirus vaccines: reasons for caution. Lancet 2004;363:2073-5.
28. Barret AD. Flavivirus DNA vaccine with a kick. Nat Biotechnol 2008;26(5):525-6.
29. Shrestha B, Diamond MS. Role of CD8+T cells in control of West Nile virus infection. J Virol 2004;78(15):8312-21.
30. Chu JH, Chiang CC, Ng ML. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. J Immunol 2007;178(5):2699-705.
31. McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, et al. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis 2007;195(11):1607-17.
32. Martina BE, Koraka P, van den Doel P, van Amerongen G, Rimmelzwaan GF, Osterhaus AD. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine 2008;26(2):153-7.
33. Qiao M, Ashok M, Bernard KA, Palacios G, Zhou ZH, Lipkin WI, et al. Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells. J Infect Dis 2004;190(12):2104-8.
34. Bonafe N, Rininger JA, Chubet RG, Foellmer HG, Fader S, Anderson JF, et al. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+cells. Vaccine 2009;27(2):213-22.
35. Lieberman MM, Clements DE, Ogata S, Wang G, Corpuz G, Wong T, et al. Preparation and immunogenic properties of a recombinant West Nile virus subunit vaccine. Vaccine 2007;25(3):414-23.
36. Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, et al. A recombinant envelope protein vaccine against West Nile virus. Vaccine 2005;23(30):3915-24.
37. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. B cells and antibodies play critical roles in the immediate defense of disseminated infection by West Nile Virus. J Virol 2003;77(4):2578-86.
38. Wang Y, Lobigs M, Lee E, Müllbacher A. CD8+T cells mediate recovery and immunopatholoy in West Nile virus encephalitis. J Virol 2003;77(24):13323-34.
39. Thomas S, Redfen JB, Lidbury BA, Mahalingam S. Antibody-dependent enhancement and vaccine development. Expert Rev Vaccines 2006;5(4): 409-12.
40. Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol 2003;16:259-78.
41. Klasse PJ, Burton DR. Antibodiesto West Nile virus:a double-edged sword. Cell Host Microbe 2007;19(12):87-9.
42. Gibbs SE, Hoffman DM, Stark LM, Marlenee NL, Blitvich BJ, Beaty BJ, et al. Persistence of antibodies to West Nile virus in naturally infected rock pigeons (Columba livia). Clin Diagn Lab Immunol 2005;12(5):665-7.
43. Baitchman EJ, Tlusty MF, Murphy HW. Passive transfer of maternal antibodies to West Nile virus in flamingo chicks (Phoenicopterus chilensis and Phoenicopterus ruber ruber). J Zoo Wildl Med 2007;38(2):337-40.
44. Hasselquist D, Nilsson JA. Maternal transfer of antibodies in vertebrates: trans-generationl effects on offspring immunity. Philos Trans R Soc Lond B: Biol Sci 2009;364(1513):51-60.